A Brief Questionnaire on Healthcare Workers’ Awareness Toward the COVID-19 Vaccine and Antibody Tests

Author:

Shimasaki Noriko1,Ishii Junko2,Kuwahara Tomoko1,Nishijima Haruna1

Affiliation:

1. Department of Virology III, National Institute of Infectious Diseases, 4-7-1 Gakuen, Musashimurayama, Tokyo 208-0011, Japan

2. Department of Neurology, Kobe City Medical Center General Hospital, Kobe, Japan

Abstract

In 2022, the coronavirus disease 2019 (COVID-19) continues to spread worldwide with the emergence of many variants. Healthcare workers (HCWs) are encouraged to be vaccinated against COVID-19 because vaccines provide powerful protection from serious illnesses, hospitalization, and death. However, breakthrough infections on vaccinees have been frequently reported, and more studies are required to understand the mechanism of breakthrough infection and establish a standard neutralizing antibody (NTAb) level with efficacy. In particular, it is important to develop useful research tools for HCWs at high risk of breakthrough infection. Here, we administered a brief questionnaire on awareness of COVID-19 vaccines and antibody tests to uncover the needs of HCWs. Our questionnaire showed that HCWs felt a lower priority for vaccines among infection control measures than non-HCWs. On the other hand, HCWs expected more strongly the vaccine to be effective in preventing infection at work than non-HCWs. About half of the respondents, whether HCWs or not, thought that there was a correlation between the severity of adverse reactions and the degree of antibody induction. About 20% of the respondents had a change in awareness of the correlation after an antibody survey. Many respondents believed that the antibody test would be useful. Therefore, we should contribute to the development of a method of evaluating vaccines that can protect against infection and to improving other infection control measures in the future.

Funder

Japan Society for the Promotion of Science

Publisher

Fuji Technology Press Ltd.

Subject

Engineering (miscellaneous),Safety, Risk, Reliability and Quality

Reference16 articles.

1. World Health Organization (WHO), “Weekly epidemiological update on COVID-19 - 10 August 2022,” Edition 104, 2022. https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19—10-august-2022 [Accessed August 20, 2022]

2. WHO, “COVID-19 advice for the public: Getting vaccinated (English version last updated on 13 April 2022),” 2022. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/covid-19-vaccines/advice [Accessed July 25, 2022]

3. Ministry of Health, Labour and Welfare, “Vaccination of healthcare workers,” (in Japanese). https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/vaccine_iryoujuujisha.html [Accessed July 25, 2022]

4. J. Jung, H. Sung, and S.-H. Kim, “COVID-19 breakthrough infections in vaccinated health care workers,” N. Engl. J. Med., Vol.385, pp. 1629-1631, 2021. https://doi.org/10.1056/NEJMc2113497

5. M. Klompas, “Understanding breakthrough infections following mRNA SARS-CoV-2 vaccination,” JAMA, Vol.326, No.20, pp. 2018-2020, 2021.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3